Florian Müllershausen

InvestorVC

Managing Director at Novartis Venture Fund

nvfund.comBasel, Switzerland

Current Investing Position

Investment Range

$5.0M - $10.0M

Sweet Spot

$7.5M

Investments On Record

Current Fund Size

$750M

Florian Müllershausen is on these Sector & Stage Rankings

Florian Müllershausen's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Rhygaze	Series AJan 2025$86M SeedJul 2024$11M	$97M
Co-investors: Daniela Couto (BGV (BioGeneration Ventures))
Citryll	Series BDec 2024$90M	$110M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures)), Geert-Jan Mulder (Forbion), Isabelle de Cremoux (Seventure Partners)
LOQUS23 THERAPEUTICS	Series AOct 2024$46M SeedNov 2021$9M	$55M
Co-investors: Rogier Rooswinkel (Forbion)
Artios Pharma	Series CJul 2021$150M Series BAug 2018$83M	$270M
Co-investors: René Kuijten (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), Hakan Goker (M Ventures (Merck))
Amphista Therapeutics	Series BMar 2021$53M	$61M
Co-investors: Satish Jindal (Advent Life Sciences), Raj Parekh (Advent Life Sciences), Rogier Rooswinkel (Forbion)
FoRx Therapeutics	SeedApr 2020$11M	$11M
Co-investors: Denis Patrick (Pfizer Venture Investments), Therese Liechtenstein (M Ventures (Merck)), Vincent Ossipow (Omega Funds), Vincent Brichard
Anaveon	Series AFeb 2019$35M	$160M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Jasper Bos (Forbion), Denis Patrick (Pfizer Venture Investments)